Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.15.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.59 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBREWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DJ.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.193EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FP.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.68 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.16.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.5.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.84 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.99EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.343EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.17 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.25.1.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.409EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.83EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.310EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.362.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.162EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Y.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.86EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.154EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.137EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.446EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.76 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.398EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.163EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.3 (Theta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.38.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAVEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.77EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used